Article Details

Affimed Presents Updated Clinical Data from Phase 1/2 Study - GlobeNewswire

Retrieved on: 2022-04-10 16:29:35

Tags for this article:

Click the tags to see associated articles and topics

Affimed Presents Updated Clinical Data from Phase 1/2 Study - GlobeNewswire. View article details on hiswai:

Excerpt

100% objective response rate and improvement in the rate of complete ... immune effector cell-associated neurotoxicity or graft versus host ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up